Comparison Between Alpelisib Plus Endocrine Therapy and Everolimus Plus Endocrine Therapy After CDK4/6 Inhibitors Progression in Patients with PIK3CA-Mutant Metastatic Breast Cancer: A Single-Center Retrospective Study
PIK3CA突变转移性乳腺癌患者CDK4/6抑制剂治疗进展后,Alpelisib联合内分泌治疗与Everolimus联合内分泌治疗的比较:一项单中心回顾性研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030468
Loizidis, Sotiris; Michaelides, Damianos; Marcou, Yiola; Kakouri, Eleni; Konstantinou, Ifigenia; Constantinidou, Anastasia; Theophanous-Kitiri, Stavroula; Papageorgiou, Elisavet; Michailidou, Kyriaki; Galazi, Myria